Mauritania vs Republic of Moldova: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Mauritania
85.0%
in 2024
Republic of Moldova
85.0%
in 2024
Mauritania rank
88th
Republic of Moldova rank
88th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Mauritania
- Republic of Moldova
How they compare
Mauritania currently reports 85.0% against 85.0% in Republic of Moldova, a difference of 0.0%.
The two have swapped places 5 times across 12 shared years of data; in 2013 it was Mauritania ahead.
Mauritania ranks 88th and Republic of Moldova ranks 88th of 146 countries.
Mauritania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mauritania | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 62.0% | 60.1% | 1.9% | Mauritania |
| 2020s | 83.8% | 79.8% | 4.0% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Mauritania or Republic of Moldova?
- Mauritania, at 85.0% against 85.0% in Republic of Moldova as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Mauritania and Republic of Moldova?
- 0.0%, with Mauritania ahead.
- How many years of comparable data are there for Mauritania and Republic of Moldova?
- 12 years are reported by both, from 2013 to 2024.
- How do Mauritania and Republic of Moldova rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Mauritania ranks 88th and Republic of Moldova ranks 88th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.